Evidence-based·Updated November 20, 2026·How we grade evidence

GlyNAC (Glycine and N-Acetylcysteine)

Amino-acidGlycine plus NAC combination

GlyNAC has a handful of small human studies, nearly all from one research group. In a 16-week randomized trial in 24 adults aged 61 to 80 with overweight, the GlyNAC group's red cell glutathione, oxidative stress markers, insulin resistance, walking speed, grip strength and waist size improved from their starting values, while the placebo group's did not. In an earlier open-label study, the gains faded after people stopped. A 2-week Nestlé trial in 114 healthy older adults found no rise in blood glutathione overall. The Baylor studies used large doses (100 mg per kg of body weight a day of each). No study has measured falls, disability or survival.

Taking GlyNAC (Glycine and N-Acetylcysteine) with other supplements or medications?Check your whole list for interactions. Free, no account.

Quick decision guide

May help most

Older adults curious about an experimental approach to age-related oxidative stress, who accept that the evidence is small and mostly from one research group and who check with their doctor first

Common dosing range

Studied doses: 100 mg per kg of body weight a day each of glycine and NAC (Baylor trials); 1.2 to 3.6 g of each a day in two doses (Nestlé trial)

When to expect effects

Blood glutathione changes were measured at 2 weeks; walking speed and strength at 16 to 24 weeks

Watch out for

The evidence is small and mostly from one group, and the studied doses are large (several grams of each a day). NAC taken by mouth can cause stomach upset, nausea, vomiting and rash. Not studied in pregnancy. In mouse studies NAC sped up lung cancer growth and melanoma spread, so people with cancer should ask their oncologist first

What is it

GlyNAC is the name researchers at Baylor College of Medicine in Houston gave to taking two supplements together: the amino acid glycine and N-acetylcysteine (NAC), a form of the amino acid cysteine. Together with glutamate, glycine and cysteine are the building blocks of glutathione, one of the main antioxidants inside cells. Most published human studies come from one research group led by Dr. Rajagopal Sekhar, in small groups of older adults, people with type 2 diabetes and people with HIV. One larger 2-week trial was run by Nestlé, which, as the paper declares, holds patents and markets products for glycine plus NAC. NAC is also an FDA-approved drug, first approved in 1963 as Mucomyst. FDA has said that this approval excludes NAC from the dietary supplement definition, but since 2022 it has used enforcement discretion for NAC products labeled as dietary supplements, and on November 17, 2026 it proposed a rule that would allow NAC to be lawfully sold as a dietary supplement (comments close January 19, 2027).

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You are an older adult interested in trying it, you understand the evidence is small and mostly from one research group, and you have checked the dose with your doctor or pharmacist
You qualify for a registered trial, such as the Vanderbilt trial of GlyNAC before and after knee replacement, listed as recruiting on ClinicalTrials.gov in November 2026

Probably skip if…

You expect proven benefits for strength, memory, diabetes or lifespan: these come from a few small studies, mostly from one group, that measured short tests and blood markers
You have cancer or are being treated for it, unless your oncologist agrees: in mouse studies NAC sped up lung tumor growth and melanoma spread
You have abnormal liver or kidney blood tests, untreated heart disease or active cancer: people with these were excluded from the randomized trial (liver enzymes over twice the upper limit of normal, creatinine over 1.5 mg/dL)
You are pregnant or breastfeeding: it has not been studied

Evidence at a glance

glutathione and oxidative stress markers in older adults

Limited Evidence
Effect
Red cell glutathione 0.4 to 1.4 mmol/L with GlyNAC; no change with placebo (small trial)
Best fit
Adults over 60 with low glutathione, as studied by the Baylor group
Time
2 to 16 weeks

walking speed, grip strength and waist size in older adults

Limited Evidence
Effect
Walking speed +0.21 m/s and grip +4.4 kg from baseline in 11 people; no change with placebo
Best fit
Adults aged 61 to 80 with overweight and no diabetes, as studied
Time
16 to 24 weeks

blood glutathione in healthy older adults over 2 weeks

Limited Evidence
Effect
No difference from placebo in total glutathione or the glutathione ratio
Best fit
Healthy older adults, as studied
Time
2 weeks

insulin resistance in older adults, type 2 diabetes and HIV

Mixed Evidence
Effect
Insulin resistance 22% to 69% lower from baseline in groups of 8 to 12
Best fit
Small groups of older adults, adults with type 2 diabetes and adults with HIV, as studied
Time
2 to 16 weeks

Evidence for 4 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

glutathione and oxidative stress markers in older adults

Biomarker support
Limited Evidence

In a double-blind trial at Baylor College of Medicine, 24 adults aged 61 to 80 with a body mass index over 27 and no diabetes were randomized to GlyNAC (100 mg per kg a day each of glycine and NAC) or an alanine placebo for 16 weeks; 11 of 12 in the GlyNAC group completed it. Red blood cell glutathione rose from 0.4 to 1.4 mmol/L of red cells (the level of the young comparison group) and muscle glutathione from 2.4 to 6.3 mmol/kg, while the placebo group stayed at 0.5 and about 2.4; markers of oxidative damage fell to levels similar to young adults. Earlier, in 8 older adults, 2 weeks of glycine plus cysteine raised red cell glutathione by 94.6%, and an open-label pilot in 8 adults aged 71 to 80 found similar changes after 24 weeks. The randomized trial was funded by the National Institute on Aging and the McNair Medical Institute, and its authors declared no conflicts. Each group was compared with its own starting values, and the trial was powered only for the glutathione result.

Effect size
Red cell glutathione 0.4 to 1.4 mmol/L with GlyNAC; no change with placebo (small trial)
Time to effect
2 to 16 weeks
Best fit
Adults over 60 with low glutathione, as studied by the Baylor group
Less likely
Healthy older adults with normal glutathione, in whom a larger 2-week trial found no overall rise

Bottom line: Small studies from one group found large rises in glutathione; a larger industry trial did not, so the finding is not settled.

Evidence is mixed

In a Nestlé-run randomized trial of 114 healthy adults aged 60 to 85 (mean age 65), 2 weeks of 1.2 to 3.6 g a day each of glycine and NAC did not raise total blood glutathione (903.5 with placebo vs 959.6 mg/L with the highest dose, p = 0.278) or the reduced-to-oxidized glutathione ratio, the main outcomes. Only a subgroup with high oxidative stress and low starting glutathione, found in an analysis after the fact, had higher glutathione (819.7 vs 905.4 mg/L, p = 0.016).

walking speed, grip strength and waist size in older adults

Supplement benefit
Limited Evidence

In the same 16-week randomized trial (24 adults aged 61 to 80 with overweight), the GlyNAC group's walking speed rose from 1.13 to 1.34 meters per second (p = .032), dominant-hand grip strength from 32.3 to 36.7 kg (p = .004), and the chair-rise test time fell from 25.6 to 18.8 seconds (p = .002); the 6-minute walk rose from 522.5 to 564.8 m, which was not statistically significant (p = .053). Waist size fell from 1.06 to 1.03 m and systolic blood pressure from 132.0 to 124.4 mmHg. None of these changed in the placebo group (walking speed 1.11 to 1.16 m/s). These are within-group changes from baseline in 11 to 12 people per group. In an earlier open-label pilot of 8 adults aged 71 to 80, walking speed rose from 1.0 to 1.5 m/s after 24 weeks and Montreal Cognitive Assessment scores from 26.0 to 28.8, but both fell back (to 1.2 m/s and 27.5) 12 weeks after stopping. Falls, disability and independence were not measured.

Effect size
Walking speed +0.21 m/s and grip +4.4 kg from baseline in 11 people; no change with placebo
Time to effect
16 to 24 weeks
Best fit
Adults aged 61 to 80 with overweight and no diabetes, as studied
Less likely
Frail older adults or people with diabetes, heart, liver or kidney disease, who were not studied

Bottom line: One small trial and one 8-person pilot found better walking speed and grip; this needs confirmation in larger trials with real-life outcomes.

blood glutathione in healthy older adults over 2 weeks

No benefit found
Limited Evidence

In a randomized, placebo-controlled trial run by Nestlé researchers in Germany, 114 healthy adults aged 60 to 85 (mean age 65) took 1.2, 2.4 or 3.6 g a day each of glycine and NAC, or an isomaltulose placebo, for 2 weeks. The main outcomes, total blood glutathione and the ratio of reduced to oxidized glutathione, did not differ from placebo (total glutathione 903.5 vs 959.6 mg/L at the highest dose, p = 0.278; ratio 12.49 vs 12.65, p = 0.739). In an analysis done afterward, people with high oxidative stress and low starting glutathione on the two higher doses had higher glutathione (819.7 vs 905.4 mg/L, p = 0.016). No severe adverse effects were reported. Nestlé Health Science holds patents and markets products for glycine plus NAC, and the study authors were Nestlé employees or worked for a research company it funded.

Effect size
No difference from placebo in total glutathione or the glutathione ratio
Time to effect
2 weeks
Best fit
Healthy older adults, as studied
Less likely
Not applicable

Bottom line: The largest trial found no overall rise in blood glutathione after 2 weeks in healthy older adults.

insulin resistance in older adults, type 2 diabetes and HIV

Biomarker support
Mixed Evidence

In the 16-week randomized trial, insulin resistance (HOMA-IR) fell by 64% and fasting insulin by 65% in the GlyNAC group, but fasting glucose and glucose tolerance tests did not change. In 10 adults with type 2 diabetes (mean age about 51), 14 days of 100 mg per kg a day each of glycine and NAC, without a placebo group, lowered insulin resistance by 22%, raised fasting fat burning by mitochondria by 30% and lowered blood free fatty acids by 25%; HbA1c did not change over the 2 weeks (9.2 to 9.1%). This study was funded by Baylor seed funding. In 8 people with HIV aged 45 to 65 on stable treatment, 12 weeks of open-label GlyNAC lowered insulin resistance by 69%, with no adverse effects; it was funded by an HIV and aging pilot grant and the McNair Medical Institute. These are blood markers in very small groups, and blood sugar control was not shown to improve.

Effect size
Insulin resistance 22% to 69% lower from baseline in groups of 8 to 12
Time to effect
2 to 16 weeks
Best fit
Small groups of older adults, adults with type 2 diabetes and adults with HIV, as studied
Less likely
Anyone hoping to replace diabetes medicines: blood sugar and HbA1c did not change

Bottom line: Insulin-resistance markers improved in very small studies, mostly without placebo; blood sugar did not change.

How it works

The body makes glutathione in two steps: cysteine is joined to glutamate, and then glycine is added. In an 8-person study, the Baylor group found that older adults had lower red blood cell levels of glycine (218.0 vs 486.7 micromol/L in younger adults), cysteine and glutathione (1.12 vs 2.08 mmol/L of red cells), and made glutathione more slowly; 2 weeks of glycine plus cysteine (given as NAC) raised their glutathione by 94.6% and lowered markers of oxidative stress. The group's theory is that restoring glutathione helps mitochondria burn fat for fuel, which in turn could improve insulin resistance, inflammation and muscle function. The theory has been tested in very few people. In the larger Nestlé trial in healthy older adults, 2 weeks of glycine plus NAC did not raise blood glutathione overall; it rose only in a subgroup with high oxidative stress and low starting glutathione, found in an analysis done after the fact.

How to take it

1. Typical dose
Studied doses, not recommendations. The Baylor trials gave capsules prepared by a pharmacist: 100 mg per kg of body weight a day each of glycine and NAC in the 2023 randomized trial and in the 2022 diabetes study, and 1.33 mmol per kg a day of glycine with 0.81 mmol per kg a day of cysteine (given as NAC) in the 2021 older-adult pilot. The Nestlé trial used powder sachets with 1.2, 2.4 or 3.6 g each of glycine and NAC a day, split into a morning and an evening dose. Your doctor or pharmacist can tell you whether it is suitable for you.
2. Higher studied dose
100 mg per kg a day of each for 16 weeks in the randomized trial, which is about 7 g of glycine and 7 g of NAC a day for a 70 kg adult.
3. Timing
Not established; the Nestlé trial split the daily amount into a morning and an evening dose.
4. With food
Not established.
5. Split dosing
Taken as two daily doses in the Nestlé trial; the Baylor papers do not compare split and single doses.
6. How long to try
Studies lasted 2 to 24 weeks. In the open-label pilot, the measured gains declined 12 weeks after stopping.

What to track

Stomach pain or discomfort, nausea, vomiting or rash, the effects most often reported with NAC taken by mouth
Liver and kidney blood tests if your doctor orders them (the trials monitored these and found no rise)
Tell your doctor and pharmacist that you take it, especially before surgery or a new medicine

Bottom line: Small studies from one group show blood-marker and short-test improvements at large doses; the one larger trial was short and found no overall glutathione rise.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

No adverse events related to the supplements were reported in the 16-week randomized trial (24 older adults) or the 24-week pilot (8 older adults), and liver and kidney blood tests did not riseIn the 2-week Nestlé trial of 114 older adults, no severe adverse effects were reported and no one stopped because of side effects; one person withdrew because of high blood pressureWith NAC taken by mouth, FDA's 2026 review found the most commonly reported effects were stomach pain or discomfort, nausea, vomiting and rash; only nausea was statistically linked to NAC, in one study

Serious risks

Who should avoid it

  • People with cancer or a history of cancer, unless their oncologist agrees: NAC sped up tumor growth and spread in mice
  • People with abnormal liver or kidney blood tests, diabetes, untreated heart disease or active cancer, unless their doctor agrees: the randomized trial excluded them (liver enzymes over twice the upper limit of normal, creatinine over 1.5 mg/dL), and asked participants to avoid acetaminophen and alcohol

Pregnancy & breastfeeding

Pregnancy: we found no study of GlyNAC in pregnancy, and the randomized trial excluded pregnant women. Breastfeeding: we found no study in breastfeeding women. Ask your obstetric clinician or pharmacist before using it while pregnant, trying to conceive or breastfeeding.

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

The amounts of glycine and of NAC (N-acetyl-L-cysteine) listed separately in milligrams per serving, so you can compare them with studied doses
Third-party testing seal (for example USP Verified or NSF) for identity and contaminants

Be skeptical of…

"Reverses aging" or "clinically proven anti-aging": based mainly on a 24-person trial of blood markers and short tests; disability, falls and survival were not measured
"Extends lifespan": a Baylor mouse study reported 24% longer life in mice; there are no human lifespan data
"Raises glutathione in everyone": the largest trial, in 114 healthy older adults, found no overall rise
"Treats diabetes": insulin-resistance markers improved in 10 people over 2 weeks without a placebo group, and blood sugar did not change
"Boosts memory" or "prevents dementia": cognitive scores rose only in an 8-person open-label pilot; trials in mild cognitive impairment and Alzheimer's disease were registered but had not reported results on ClinicalTrials.gov
"Safe at any dose": the studies were small and short, and NAC can cause stomach upset, nausea, vomiting and rash

Frequently asked questions

What is GlyNAC, and is it different from taking NAC alone?⌄

GlyNAC is glycine plus N-acetylcysteine (NAC) taken together, a combination named by researchers at Baylor College of Medicine. Both supply building blocks of glutathione. The Baylor group argues that older adults are short of both glycine and cysteine, so NAC alone is not enough, but no published trial has compared GlyNAC directly with NAC alone or glycine alone.

Does GlyNAC slow aging?⌄

That has not been shown. A 16-week trial in 24 older adults found improvements in blood markers, walking speed, grip strength and waist size compared with each group's starting point, and an 8-person pilot found the gains faded after stopping. A larger 2-week trial found no overall rise in blood glutathione. No study has measured disability, falls or how long people live.

How much did the studies use?⌄

The Baylor studies used 100 mg per kg of body weight a day each of glycine and NAC, which is about 7 g of each a day for a 70 kg adult. The Nestlé trial used 1.2 to 3.6 g of each a day split into two doses. These are studied doses, not recommendations: ask your doctor or pharmacist whether any amount suits you.

Who ran and paid for the studies?⌄

Most were run by Dr. Rajagopal Sekhar's group at Baylor College of Medicine and were funded by the National Institute on Aging, the McNair Medical Institute and other grants; the authors declared no conflicts of interest. The 114-person trial was run by Nestlé researchers, and Nestlé Health Science holds patents and markets products for glycine plus NAC.

Is NAC allowed in dietary supplements?⌄

FDA says NAC was approved as a drug in 1963, which excludes it from the dietary supplement definition, but since 2022 FDA has said it intends to use enforcement discretion for NAC products labeled as dietary supplements. On November 17, 2026 FDA proposed a rule that would allow NAC to be lawfully marketed as a dietary supplement; comments are open until January 19, 2027.

Can I take GlyNAC with my medicines or supplements?⌄

No interaction studies of the combination exist. Glycine and NAC each have their own pages that list their checked interactions, so look up both. Ask your doctor or pharmacist to review your full list, especially if you are being treated for cancer or have surgery planned.

References by claim

glutathione and oxidative stress markers in older adults

Kumar et al., 2023 · PMC (2023) link

Sekhar et al., 2011 · PMC (2011) link

Kumar et al., 2021 · PMC (2021) link

Lizzo et al., 2022 · PMC (2022) link

insulin resistance in older adults, type 2 diabetes and HIV

Sekhar et al., 2022 · PMC (2022) link

Kumar et al., 2020 · PMC (2020) link

Safety

Federal Register, November 17, 2026 (91 FR 73717): Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition (proposed rule) · FDA link

Sayin et al., 2014 · PubMed (2014) link

Le Gal et al., 2015 · PubMed (2015) link

Track GlyNAC (Glycine and N-Acetylcysteine) with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 20, 2026·Evidence current as of Nov 20, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments. Talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.